Zynerba Pharmaceuticals Overview
Zynerba Pharmaceuticals Discounted Cash Flow
DCF Analysis for ZYNE.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.03
Current Fair Value
$3.03
↑ 132.9% Upside
Undervalued by 132.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison